Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia

American Journal of Cardiology

Volumn 87, Issue 3, 2001, Pages 338-340

  Wierzbicki, Anthony S ^a   Lumb, Peter J ^a   Chik, George ^a   Crook, Martin A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOGEN; HEPTANOIC ACIDS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PYRROLES; RISK FACTORS; SIMVASTATIN;

EID: 0035253106     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01371-0     Document Type: Article

References (20)

1. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
2. Hemostatic risk factors and prevalent coronary heart disease: The FINRISK hemostasis study
3. Anti-atherothrombotic properties of statins: Implications for cardiovascular event reduction
4. Effects of atorvastatin on plasma fibrinogen
5. Efficacy of atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidemias
6. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
7. Increased thromboxane synthesis in type IIa hypercholesterolemia
8. More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia
9. Atorvastatin and fibrinogen - A small subgroup shows extreme response
10. Statins and fibrinogen
11. Statins and fibrinogen
12. Effects of simvastatin, a 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitor, on the hemostatic balance of familial hypercholesterolemic subjects
13. Pravastatin therapy in hyperlipidemia: Effects on thrombus formation and the systemic hemostatic profile
14. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects
15. Statins and fibrinogen
16. Long-term effects of pravastatin on plasma C-reactive protein
17. Effect of statins on C-reactive protein in patients with coronary artery disease
18. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia
19. Heterozygous familial hypercholesterolemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy
20. Measuring plasma fibrinogen to predict stroke and myocardial infarction